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Accepted 28 July 2016The possible interaction between Pasteurella multocida and themycotoxin fumonisin B1 (FB1), recognised as one
of the most often food/feed contaminant, was studied with the aim to evaluate whether and how FB1 can inﬂu-
ence and/or complicate the development and severity of various pathological damages provoked by Pasteurella
multocida in some internal organs of pigs. Heavier lung pathology was seen in pigs experimentally infected
with Pasteurella multocida, when the same were exposed to 20 ppm dietary levels of fumonisin B1 (FB1) as was
assessed by gross pathology, pathomorphological examinations, clinical biochemistry and some immunological
investigations. The most typical damages in FB1 treated pigs were the strong oedema in the lung and the slight
oedema in the other internal organs and mild degenerative changes in the kidneys, whereas the typical
pathomorphological ﬁndings in pigs infected with Pasteurella multocida was broncho-interstitial pneumonia.
FB1 was found to aggravate pneumonic changes provoked by P. multocida in the cranial lobes of the lung and
to complicate pneumonic damageswith interstitial oedema in the lung. Nomacroscopic damageswere observed
in the pigs infected only with Pasteurella multocida. It can be concluded that the feed intake of FB1 in pigs may
complicate or exacerbate the course of P. multocida serotype A infection.
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Pigs1. Introduction
Mycotoxins are toxic secondary metabolites produced by certain
fungi that grow in target agricultural products susceptible tomold infes-
tation. The most mycotoxins have strong immunosuppressive effects
and often compromise animals and human health provoking develop-
ment of secondary bacterial infections (Stoev et al., 2000) or deteriorat-
ing some existing diseases (Pósa et al., 2011, 2013). It is well known,
that Fumonisin B1 (FB1) is one of the most frequent contaminant of
the feeds for pigs in all over the world (Dutton, 2009). In Hungary, FB1
was found in relatively high percentage of maize used as animal feed
(Fazekas et al., 1998).
FB1 was found to be the cause of a number of outbreaks of equine
leukoencephalomalacia (Conkova et al., 2003) and porcine pulmonaryfumonisin B1; PA, phagocytic
e; SO, sphingosine; TNF, tumor
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burg, South Africa.oedema killing many horses and pigs in the U.S. during 1989 and 1990
(Marasas, 2001). These lesions appeared to be a consequence of impair-
ment of vascular permeability provoked by disruption of sphingolipid
metabolism by FB1 (Ramasamy et al., 1995). FB1 is also suspected to
be responsible for the pulmonary ﬁbrosis in pigs, which develops in
the case of chronic exposure and follows oedematous changes in the
lung (Zomborszky-Kovács et al., 2002).
Some studies clearly conﬁrmed that immunosuppression may be the
ﬁrst expressed toxic effect of some mycotoxins, such as ochratoxin A
(Stoev et al., 2000). It was also found that FB1 given at diet levels of
10 ppm, has immunosuppressive effect on humoral immune response
in pigs (Stoev et al., 2012) and therefore can provoke some secondary
bacterial infections, which arise in immunocompromised animals. In
this regard,Oswald and collaborators observed a signiﬁcant increase of in-
testinal colonization of pathogenic Escherichia coli in FB1-treated pigs
(Oswald et al., 2003). On the other hand, a heavy progression of
Pasteurella multocida (Halloy et al., 2005) or porcine reproductive and re-
spiratory syndrome (PRRS) virus infections in swine (Ramos et al., 2010)
were seen when the same animals were compromised by feed exposure
to FB1. There are also some recent reports about aggravations of patholog-
ical infections in pigs, when fed on FB1 contaminated diet (Pósa et al.,
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tion between FB1 and some frequent infectious pathogens in pigs can be
evaluated as insuﬁcient and scarce. As FB1 is a frequent contaminant of
pigs' diet, and P. multocida is the most frequent secondary pathogen
which can generate a respiratory disorder in predisposed or immuno-
compromised pigs (Halloy et al., 2005), such studies could have signiﬁ-
cant scientiﬁc and/or practical importance. In this regard, the data on
the predisposing effect of FB1 on the appearance and/or progression of
the lesions provoked by toxigenic strain of P. multocida, serotype A and
the interaction between the toxin and the bacterium are scarce (Halloy
et al., 2005), independently of the circumstance that both agents (toxic
and infectious) have the same target organ localization (lung), and the
same can be encountered simultaneously in the pig production farms.
It is also implied the problem of recognising the pathological damages
provoked by FB1 and/or the respective infectious agents, especially in the
casewhen such damages are very similar or localized in the same internal
organ such as lung. In our former experimentwe found that feeding a diet
containing 10 ppm FB1, in combinationwith Bordetella bronchiseptica and
toxigenic Pasteurella multocida serotype D infection, increased the inci-
dence and the extension of pulmonary lesions in pigs as well as aggravat-
ed the severity of the same lesions (Pósa et al., 2011). This experiment is
the next step of our framework programme designed to reveal what can
be the real adverse effects of FB1 on various contagious or non-contagious
diseases having similar pathology and whether the same mycotoxin is
able to facilitate or complicate the typical pathological ﬁnding of these
diseases. In the current experiment, we also studied the possible interac-
tion of Pasteurella multocidawith the mycotoxin FB1, recognised respec-
tively as one of the most often food/feed contaminant, with the aim to
evaluatewhether andhowFB1 can inﬂuence and/or complicate thedevel-
opment and/or severity of various pathological changes provoked by
Pasteurella multocida in some internal organs of pigs.
2. Materials and methods
2.1. Experimental design
The piglets used in this study were obtained from a Seghers hybrid
herd (Hungaro-Seghers Ltd., Mohács) in which the incidence of respira-
tory diseases was low and were free from ﬁve major infectious diseases
(Brucellosis, Leptospirosis, Pasteurellosis, Aujeszky and porcine repro-
ductive and respiratory syndrome – PRRS). The sows (n= 10) deliver-
ing the piglets were also serologically free from Pasteurella multocida
and serologically negative forM. hyopneumoniae. Twenty eight 3-days
old female piglets of 2.25 ± 0.3 kg average body weight, obtained
from the same sows and received colostrum to get maternal (colostral)
immunitywere divided in four groups (7 piglets in each) using the prin-
ciple of equality, and housed in two separate rooms in elevated-level
battery cages of identical size as follow: (1) the twonon-infected groups
(Group A — controls and Group B — FB1 exposed) were kept in one of
the rooms in two separated cages, and (2) the infected with Pasteurella
multocida groups (Group C and GroupD— FB1 exposed)were housed in
the other room in a similar way. Both rooms were adjusted to identical
air temperature (27 °C) using thermostat-regulated central heating,
while the required air exchange was ensured by the use of exhaust
fans. The battery cages, the drinkers and the rooms were cleaned
twice a day, and the piglet-rearing installations were dismantled and
washed off every second day. The respective hygienic and/or protective
measures as wearing of protective clothes and foot & hand disinfection
with the aqueous solution of Virkon S (KRKA d. d./Antec International
Ltd., NovoMesto, Croatia)were strictly respected at the time of entering
or exiting the rooms.
2.2. Feeding and water supply
Up to day 16 from the birth all experimental pigletswere fed onmilk
replacer consisting of skimmed milk powder, vegetable fats and wheypowder, containing 23% crude protein, 23% crude fat and 1.6% lysine
(Salvana Ferkel Ammen Milch, Salvana Tiernahrung GmbH, Klein-
Offenseth Sparrieshoop, Germany) from an automatic feeder (Sloten
B.V., Deventer, The Netherlands).
From day 7, a dry creep feed of coarse meal form, containing 16 MJ/
kg energy, 18.5% crude protein, 9% crude fat and 1.65% lysine (Salvana
Pre-meal, Salvana Tiernahrung GmbH, Klein-Offenseth Sparrieshoop,
Germany) was also given ad libitum to the piglets, and then, from day
16 until the end of the experiment (day 40) only the latterwas available
to them.
Fresh drinking water was available ad libitum from nipple drinkers.
At the beginning of the experiment (between day 0 and 7), drinking
water was also provided by the free water surface of the plastics drink-
ing bowls.
2.3. Mycotoxin exposure
The necessary quantity of FB1 was produced by the fungus Fusarium
verticillioides as described previously (Fodor et al., 2006) as theﬁnal fun-
gal culture typically contained 3–4mg/g FB1, and small quantities of less
toxic compounds FB2 and FB3 (0.3–0.6mg/g). Starting fromday 14, a de-
ﬁned quantity of the same fungal culture was thoroughly homogenised
into the piglets' ration of groups B and D to give the required concentra-
tion of 20 ppm (mg/kg feed) FB1 in the diet and these groups were ex-
posed to the same feed levels of FB1 until the end of the experiment
(day 40), i.e. over a period of 26 days.
FB1 and FB2 concentration in the fungal culture and in the diet was
checked using LC-MS system (LC-MS 2020 Single Quadrupole Mass
Spectrometer, LC-20AD pumps with DGU-20A degasser, SIL-20ACHT
autosampler, CTO-20-AC Column Owen and CBM-20A Interface,
SHIMADZU, Kyoto, Japan), and the diet did not contain other myco-
toxins (such as T-2, zearalenone, deoxynivalenol, ochratoxin A, aﬂa-
toxins, etc.) in detectable quantities. Concentration of T-2 and total
aﬂatoxin was measured by ELISA kits, AgraQuant® T-2 Toxin Assay
and AgraQuant® Total Aﬂatoxin Assay (RomerLabs, Singapur), respec-
tively, following the instructions of the producer. The basic diet was
also free from detectable quantities of the mycotoxins assayed.
2.4. Experimental infection
On day 14, the pigs of groups C and D were infected with toxigenic
strain of Pasteurella multocida serotype A (strain DE3011,
4.4 × 108 CFU/mL). The bacterial suspensions were prepared as de-
scribed previously (Magyar et al., 2002). A volume of 1.0 mL was inocu-
lated through an endotracheal tube in all cases.
Microbiological investigations revealed no presence of other respira-
tory pathogens in the inoculum aswell as in the lungs of the control and
infected pigs at the end of the study except the main pathogen
Pasteurella multocida found only in experimentally infected pigs.
2.5. Immunisation with ovalbumin
All piglets were injected intraperitoneally with 100 μg ovalbumin/
animal on days 19 and 27 in order to provoke immune response.
100 μg ovalbumin was solved in 400 μL phosphate buffered saline
(PBS, Sigma-Aldrich, Hungary) and thereafter 400 μL incomplete Freund
adjuvant (Sigma-Aldrich, Hungary) was added.
2.6. Blood clinico-biochemical and immunological investigations
Blood samples were taken from the v. cava cranialis on days 14 (the
beginning of the experiment), 27 and 39 after the respective narcosis
and premedication as described below.
Serum clinical/biochemical parameters were determined in a pro-
fessional veterinary laboratory (Vet-med Laboratory, Budapest, Hunga-
ry), using Roche Hitachi 912 Chemistry Analyzer (Hitachi, Tokyo, Japan)
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respectively. The concentration of total protein (TP), albumin (ALB),
glucose (G), total cholesterol (CHOL), urea, and the activity of alanine
aminotransferase (ALT), aspartate aminotransferase (AST) and
gamma-glutamyl transferase (GGT) were measured as appropriate.
At the end of the experiment the blood samples taken during exsan-
guination (see later) were analysed for certain immunological
parameters.2.7. Phagocyte number and phagocytic activity
Thedetermination of number of phagocytic cells andphagocytic activ-
ity (PA) was done according to Simpson et al. (1979) as described in Ma-
terial andMethodswith somemodiﬁcations. Peripheral white blood cells
(WBC) were isolated by density gradient centrifugation (400 ×g for
15 min) using Ficoll-Paque (Pharmacia) according to standard protocols.
The number of viable PBLs was determined by trypan blue exclusion in a
haemocytometer. The cells were diluted in DMEM supplemented with
penicillin and streptomycin (Sigma-Aldrich, Hungary) antibiotics and
10% fetal bovine serum. Cells were plated at 1 × 105 cells/well density
into 6 well plates. The cultures were incubated for 4 days at 37 °C under
5% CO2 tension.
PA was determined with Congo-red stained yeast cells by incubating
overnight at 37 °C. Phagocytic ability was expressed as percentage of
phagocytic cells quantiﬁed from 100 cells observed under a microscope.2.8. Ovalbumin Speciﬁc IgG and tumor necrosis factor alpha (TNF) from the
blood
Speciﬁc circulating antibody titers were measured using microti-
ter plates (Sigma-Aldrich, Hungary) coated with 100 μL of ovalbumin
solution (10 μg/mL ovalbumin in PBS) per each well, incubated over-
night at 4 °C in a humidiﬁed environment. Excess protein was re-
moved by washing with 3 × 150 μL PBS-Tween 20 (Sigma-Aldrich,
Hungary). Plasma samples were twofold serially diluted in the wash-
ing solution, starting with 1:50, in a separate plate. Aliquots of 100 μL
of each dilution (1:50 and 1:100) were transferred to the microtiter
plate (two wells for each dilution) and incubated for 1 h at room
temperature. Wells were washed again 3 times with PBS-Tween
and anti-swine IgG-HRPO conjugate (Sigma-Aldrich, 1:25,000) was
added to each well, followed by incubation at RT for 1 h. The
wash step was then repeated and the substrate (3,3′,5,5′-
Tetramethylbenzidine, Sigma-Aldrich) added. Optical density was
measured in an ELISA reader at 450 nm.
For tumor necrosis factor alpha (TNF-α) quantiﬁcation total RNA
was puriﬁed from blood samples using the InnuPREP Blood RNA Kit
(Analytikjena) as recommended by the manufacturer. Reverse tran-
scription of the RNA templates was performed with the M-MuLV
RevertAid™ Reverse Transcriptase using random hexamer primers
(100 pmol/sample) (Fermentas, Lithuania). Polymerase chain reac-
tion was done according to the method described by Jung et al.
(2007), serial dilutions of cloned cDNA were used for generating a
standard curve of concentration. Melting curve analysis to conﬁrm
target-speciﬁc ampliﬁcation was performed following PCR.2.9. IgA from the lung lavage ﬂuid taken at necropsy
Total amount of IgA antibodies present in bronchoalveolar lavage
was measured using a direct sandwich IgA ELISA kit (Abcam) follow-
ing the manufacturer's recommendations. Samples were diluted
1:1000 in sample diluent, standard curve was constructed by mea-
suring the OD of twofold dilutions of the standard IgA provided
with the kit.2.10. Bronchoalveolar lavage (BAL)
Bronchoalveolar lavage (BAL)wasperformed aseptically at necropsy
(on day 40) with 50ml PBS. Lavage ﬂuid was gently dispensed into and
aspirated from the right cranial, middle, and caudal lung lobes.
2.11. Gross pathology and pathomorphological examination
At the end of the experiment (on day 40) the pigs were narkotized
with sodium-pentobarbital (Euthanyl, Bimeda, MTC Animal Health)
and thereafter exsanguinated and subsequently examined for
macroscopical and pathomorphological changes in various internal or-
gans. Materials for histological examination were taken from the lung
(areas with and without macroscopic changes), trachea, kidneys, liver,
hearth, brain, cerebellum, spleen, mesenterial lymph nodes, small and
large intestine and thenﬁxed in 10%neutral buffered formalin. Fixed tis-
sues were embedded in parafﬁn wax, sectioned at 6 μm and stained
with hematoxylin-eosin. Periodic acid — Schiff stain was also used for
proving of lipoproteid, glycoproteid or mucoproteid substances in vari-
ous tissues and cell components. Some materials were stained accord-
ing to Weigert iron hematoxylin for proving the presence or absence
of ﬁbrin in lymphatic cysts or oedematous areas.
2.12. Body weight and health status
The clinical signs (including nasal discharge, sneezing, panting,
hoarseness, coughing and dyspnoea) as well as body temperature
were recorded daily during the experiment. The piglets were weighed
on 3, 14, 27 and 40days of age. Feed consumption of the groupswas reg-
istered daily.
2.13. Sphingolipid proﬁle test
At the end of the experiment (on day 40) the free sphinganine to
sphingosine ratio, the most sensitive biomarker of fumonisin toxicosis
(Riley et al., 1993), was determined in the blood serum by amethod de-
scribed by Kametler et al. (2006).
2.14. Statistical analysis
Statistical analysis of the data obtained was carried out by the SPSS
for Windows statistical software package using the version 11.5 (SPSS,
2002). Effect of treatment was analyzed by the One-Way Analysis of
Variance. The signiﬁcance of between group differences was tested by
the LSD post hoc test.
2.15. Animal welfare permission and ethical standards
The experimental design as well as the housing, maintaining and
slaughtering of pigs was performed in accordance with European
Guidelines and Ethic Principles for the care and use of animals for re-
search purpose and the HungarianWelfare Regulations. The study pro-
tocol, i.e., experimental infection, blood sampling applied in this study
were authorised by the Food Chain Safety and Animal Health Director-
ate of the Somogy County Agricultural Ofﬁce, under the permission
number SOI/31/241–3/2013.
3. Results
3.1. Growth rate, clinical signs
There were no signiﬁcant differences in the body weight of the pigs
between various experimental groups as measured on days 14, 27 and
39 of the experiment.
No clinical signswere observed in the control and FB1 treated groups
throughout the experiment. In P. multocida infected groups (C and D),
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animals in the group exposed simultaneously to FB1 and P.multocida ex-
hibited a temporary increase in the body temperature and slight
coughing in addition to occasional sneezing and a slight serous nasal
discharge.
3.2. Biochemical and immunological investigations
On day 39, the free sphinganine (SA) to sphingosine (SO) ratio (SA/
SO), known to be a biomarker of FB1 toxin, was signiﬁcantly elevated
(P b 0.05) in the blood of groups B and D (2.41 ± 0.49 and 2.7 ± 0.45,
respectively) exposed to FB1 as compared to the groups A and C fed
on toxin free diet (0.68± 0.11 and 0.72± 0.44, respectively), indicating
that there was an effect exerted by the toxin at a cellular level.
Among blood clinical chemical parameters ALT and AST revealed
mild hepatic injury in toxin treated animals, as enzyme activities were
signiﬁcantly higher on the 3rd sampling dates in these animals com-
pared to controls or infected (but not FB1 treated) animals (Table 1).
Phagocyte count and activity, aswell as speciﬁc IgG and the cytokine
TNF did not respond on any of the treatments. Only locally secreted IgA
concentration in the lung was altered in FB1 treated groups, resulted in
less antibody production (Table 2).
3.3. Gross pathology
The blood vessels in themesenterium in somepigs of the control and
experimental groups were slightly hyperaemic. Mesenterial lymph
nodes of the same pigs were slightly enlarged and small foci of local
peritonitis were seen in most of the pigs (experimental and control).
3.3.1. Control pigs
Generally, there were not any persistent macroscopical changes in
the internal organs evaluated in the pigs from the control group, exclud-
ing a small swelling in the thymus of one pig from this group looking-
like an abscess.
3.3.2. Fumonisin B1 treated pigs
Macroscopic ﬁndings during the necropsy revealed that kidneys of
pigs from this group were slightly pale than normal with rarely seen
focal hyperaemic areas. The interstitial tissue of lung in all examined
pigs was well visible and thickened, which suggested about interstitial
oedema in the lung (Fig. 1). Slight hyperaemiawas seen in the brain en-
velopes. Gall bladder was slightly enlarged only in one pig of this group.Table 1
Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) activity in the
blood serum of pigs exposed to FB1 and/or infectedwith P. multocida compared to control
animals.
Age (days) at sampling
AST (U/l)
14 27 39
Mean SD Mean SD Mean SD
A (control) 31,9 8,9 47,6 14 21,7a 8,1
B (FB1) 29,9A 4,7 62,8B 11,2 42,6bAB 15
C (Pm) 29,1 7,7 43,3 18 31,8a 6,5
D (Pm + FB1) 31,3A 6,4 50,6AB 17,9 47,3bB 4,1
14 27 39
ALT (U/l) Mean SD Mean SD Mean SD
A (control) 37,3A 6,8 51,4AB 8,7 63,8aB 5,6
B (FB1) 44,7A 5,8 56,7A 10,5 75,7bB 5,3
C (Pm) 37,9A 5,4 57,3B 9 60,6aB 4,3
D (Pm + FB1) 40,1A 3,7 60AB 15,4 75,7bB 7,8
Different indices indicate signiﬁcant difference between (a,b) treatments or (A,B) sampling
dates.
FB1: fumonisin B1, Pm: Pasteurella multocida, C: control.3.3.3. Pasteurella multocida infected pigs
Macroscopic ﬁndings during the necropsy revealed that kidneys of
pigs were slightly pale. Spleen of one pig was only enlarged. Jejunum
of pigs showed signs of local inﬂammation (jejunitis). The gall bladder
was slightly enlarged in part of the pigs of this group. In the lung, only
small bluish to reddish pneumonic areas were sometimes observed in
the cranial lobes.
3.3.4. Fumonisin B1 treated and Pasteurella multocida infected pigs
Macroscopic ﬁndings during the necropsy revealed that kidneys of
pigs from this group were slightly pale than normal with rarely seen
focal hyperaemic areas. The interstitial tissue of lung in all examined
pigs was well visible and thickened, which suggested about interstitial
oedema or pneumonia in the lung. Small bluish to reddish pneumonic
areas were observed sometimes in the cranial lobes. Slight hyperaemia
and purulent exudate was observed in the nasal cavity around the
conch. Slight hyperaemia was seen in the brain envelopes. Jejunum of
pigs showed signs of local inﬂammation (jejunitis). Gall bladder was
slightly enlarged in most of the pigs of this group. Spleen of 3 pigs was
enlarged.
3.4. Pathomorphological ﬁndings
3.4.1. Control pigs
Generally, therewere not any persistent pathomorphological chang-
es in various internal organs of the pigs from control group, excluding
slight degenerative changes in the liver and some degenerative and/or
necrotic changes in addition to leucocyte inﬁltration in the thymus of
one pig, which could be bound to macroscopic visible abscess in the
same organ.
3.4.2. Fumonisin B1 treated pigs
Pathomorphological investigation revealed that the most typical
pathomorphologiacal damage in the pigs of this group was seen in the
permeability of vessels, which was responsible for perivascular and es-
pecially pericapillary oedema in various internal organs and especially
in the lung.
In the lung, the most typical pathomorphological changes were the
oedema and accumulation of serous or sero-ﬁbrinous exudate in the in-
terlobular or perivascular tissue of all examined pigs (Fig. 2). Increased
quantity of themucus on themucosal surface and a slight oedema in the
mucosa or submucasa were seen also in the trachea (Table 3).
In the brain, only slight hyperaemia and perivascular or pericellular
oedema and slight vacuolization or colliquative (lytic) changes in the
cortex of the brain as well as lytic changes in some of the neurons and
glia cells were seen. Slight hyperaemia and oedema were also seen in
the brain envelopes and/or ventricles.
In the cerebellum, the only recognized damages were the slight
edema and degenerative changes (mainly lysis) in the region of the
Purkinje's cells as well as the slight lytic or colliquative changes in the
corpus medullare or laminae medullares of white matter.
In the kidneys, the most persistent pathomorphological changes
were the slight or moderate vacuolar/granular degeneration in the epi-
thelium of proximal tubules, the hyperaemia of vessels and peritubular
capillaries, the slight activation of capillary endothelium, the
perivascular or pericapillary edema and the slight enlargement of lym-
phatic spaces.
In the liver, the irregular staining (eosinophilia or cloudy swelling)
or slight degenerative changes in some hepatocytes and the slight
hyperaemia of vessels and the slight activation of capillary endothelium
were observed.
In the spleen, there was only a slight hyperaemia and sometimes a
slight enlargement or oedema in the trabeculae.
In themesenterial lymph nodes, pathomorphological changes corre-
sponding to lymphadenitis simplex such as enlargement and
Table 2
Immunological parameters (mean ± SD) of pigs exposed to FB1 and/or infected with P. multocida compared to control animals at the end of the experiment (at day 39 of their age).
Group Phagocyte count/ml1 Phagocyte activity (%)1
TNF2
(Ct value)
IgG2
(mg/ml)
IgA3
(mg/ml)
A (control) 366 ± 15 81 ± 3 20.0 ± 1.6 6.7 ± 0.8 5.4 ± 0.3a
B (FB1) 362 ± 26 80 ± 3 19.7 ± 1.9 5.4 ± 0.9 4.4 ± 0.4b
C (Pm) 375 ± 13 80 ± 3 20.4 ± 1.2 5.7 ± 0.9 4.9 ± 0.3a
D (Pm + FB1) 383 ± 41 79 ± 3 19.4 ± 2.0 5.7 ± 0.7 4.4 ± 0.3b
Different indices (a,b) indicate a signiﬁcant difference between treatments.
FB1: fumonisin B1, Pm: Pasteurella multocida, C: controls.
1 Measured in whole blood.
2 Blood plasma.
3 Lung lavage ﬂuid — it is only taken at day 40.
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some of the pigs.
In the small- and large intestines, only slight degenerative changes
in superﬁcial epithelium or slight increasing of the glandular secretion
and the quantity of Goblet cells, were seen.
In themyocardium, the only observed changes were irregular stain-
ing or slight lytic changes in some myoﬁbrils.
3.4.3. Pasteurella multocida infected pigs
Pathomorphological investigation revealed that the most common
pathomorphologiacal damage in the pigs of this group was seen in the
lung. The thickening of the alveolar septa due to a slight to moderate
mononuclear inﬂammatory inﬁltration containingmainlymacrophages
and a small quantity of lymphocytes and/or leucocytes was seen in
some regions of the lung. The same mononuclear cell inﬁltration was
also seen in interlobular and perivascular or peribronchiolar interstitial
tissue. An exudate containing the same mononuclear cells and
leucocytes was rarely present in the alveolar lumens and sometimes
in the bronchioles only in two pigs of this group. A slight proliferation
and/or hyperplasia of alveolar/bronchiolar epithelium were also ob-
served (Fig. 3). A slight to moderate congestion of capillaries and larger
vessels was seen. The same lesions were located in the cranial and
slightly in the caudal lobes. Increased quantity of the mucus was seen
also in the trachea.
In the brain, therewere not any visible pathological changes. A slight
perivascular and/or pericellular oedema and a slight vacuolization or
colliquative (lytic) changes in the cortex under the brain envelopes
was observed only in one of the pigs examined. A slight hyperaimia of
vessels in the brain envelopes was rarely seen.
In the cerebellum, there were not any visible pathological damages.
Only a slight hyperaemia of some vessels was seen.Fig, 1. Thickened interstitial tissue suggesting for interstitial oedema in the lung. Lung of
pig given FB1.In the kidneys, there were not any signiﬁcant pathological damages.
In the liver, the irregular staining (eosinophilia or cloudy swelling)
or slight degenerative changes, mainly granular degeneration in some
hepatocytes were only observed.
In the spleen, there were not any visible pathological changes, ex-
cluding the slight predomination of red pulp over the white pulp in
some of the pigs.
In themesenterial lymph nodes, pathomorphological changes corre-
sponding to lymphadenitis simplexwere rarely seen in some of the pigs.
In the small- and large intestines, slight degenerative changes were
seen in superﬁcial epithelium in addition to a slight increasing of the
glandular secretion, incl. The increasing of the quantity of Goblet cells
and a local histiocyte proliferation.
In the myocardium, no pathological changes were seen.
3.4.4. Fumonisin B1 treated and Pasteurella multocida infected pigs
Pathomorphological investigation conﬁrmed that themost common
pathomorphologiacal damage in the pigs of this groupwas seen again in
the permeability of vessels and the subsequent perivascular and espe-
cially pericapillary oedema in various internal organs and especially in
the lung.
The most typical pulmonary damages were the thickening of the al-
veolar septa due to a slight to moderate mononuclear inﬂammatory in-
ﬁltration containing mainly macrophages and a small quantity of
lymphocytes and/or leucocytes. Slight or moderate oedema and accu-
mulation of serous or sero-ﬁbrinous exudate in the interlobular or
perivascular tissue were seen. The same inﬂammatory mononuclear
cell inﬁltration was also seen in interlobular and perivascular or
peribronchiolar interstitial tissue. An exudate containing the same
mononuclear cells, desquamated epithelial cells and a lot of leucocytes
was often present in the alveolar lumens and sometimes in theFig. 2. Oedema and accumulation of serous or sero-ﬁbrinous ﬂuid in the interlobular
tissue. Lung of pig given FB1. X/E. ×200.
Table 3
Pathomorphological lesions in some internal organs of the pigs exposed to FB1 and/or in-
fected with P. multocida at the end of the experiment (at day 40 of their age).
Pathomorphological lesions in the lung FB1 Pm FB1 + Pm
Oedema and accumulation of serous or seroﬁbrinous
exudate in interlobular and/or perivascular tissue
++++ − +++++
Thickening of interalveolar septa due to
inﬂammatory cell inﬁltration of macrophages,
lymphocytes and leucocytes
− ++ +++
Proliferation and/or hyperplasia of
alveolar/bronchiolar epithelium
− ++ ++
Perivascular/peribronchiolar/interlobular
mononuclear cell inﬁltration of macrophages,
lymphocytes and leucocytes
− ++ +++
Accumulation of exudate with a lot of leucocytes,
macrophages and/or desquamated epithelial cells
in the alveolar lumina and in the bronchi or
bronchioles
− + +++
Increased quantity of mucus on the mucosal surface
and/or oedema in the tracheal mucosa or
submucosa
++ + +++
Hyperaemia of capillaries or larger vessels − ++ +++
Pathomorphological lesions in the brain
Perivascular and/or pericellular oedema +++ + +++
Oedema in the meninges or ventricles ++ − ++
Hyperaemia in the brain or meninges ++ + ++
Lytic changes and/or vacuolization in the cortex ++ + ++
Lytic changes in the neurons and glia cells ++ − ++
Pathomorphological lesions in the cerebellum
Oedema and lysis in the region of the Purkinje's cells ++ − ++
Lytic changes in the white matter ++ − ++
Hyperaemia of vessels − + +
Pathomorphological lesions in the kidneys
Vacuolar or granular degeneration in the tubular
epithelium
++ − +++
Hyperaemia of vessels and peritubular capillaries ++ − ++
Activation of capillary endothelium + − +
Perivascular oedema and enlargement of lymphatic
spaces
++ − ++
Oedema around the ureters and hyaline casts in
tubules
− − +
Pathomorphological lesions in the liver
Cloudy swelling and granular degeneration in
hepatocytes
+ + +
Hyperaemia and activation of capillary endothelium + − +
Pathomorphological lesions in the spleen
Oedema and/or hyperaemia in the trabeculae + − +
Predomination of red pulp over the white pulp − + +
Pathomorphological lesions in the intesines/mesent. lns
Enlargement of lymph follicles in mesenterial lymph
nodes
+ + +
Increase in glandular secretion and degenerative
changes
+ + +
Pathomorphological lesions in the myocardiums
Irregular staining or lytic changes in some myoﬁbrils + − +
+− slight damage or damage seen occasionally in few pigs.
++− slight to moderate damage seen in less than half of the pigs.
+++−moderate damage seen in all pigs or strong damage seen in less than half of the
pigs.
++++− strong damage seen in more than half of the pigs, but not all of them.
+++++− strong damage seen in all pigs.
FB1: fumonisin B1, Pm: Pasteurella multocida.
Notes: No damages were found in control animals (Group A) except slight hyperaemia of
vessels, which was presumably due to the narcosis.
Fig. 3. Thickening of the alveolar septa due to a slight to moderate mononuclear
inﬂammatory inﬁltration of macrophages and lymphocytes and/or leucocytes in
addition to proliferation of alveolar and/or bronchiolar epithelium. An exudate
containing the same cells and leucocytes in alveolar/bronchiolar lumens. Lung of pig
infected with P. multocida. X/E. ×260.
Fig. 4. An exudate containing mononuclear cells, desquamated epithelial cells and a lot of
leucocytes in the alveolar lumens and bronchioles. Accumulation of serous or sero-
ﬁbrinous exudate in the interlobular or perivascular tissue. Lung of pig given FB1 and
infected with P. multocida. X/E. ×260.
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or hyperplasia of alveolar/bronchiolar epitheliumwere also observed. A
slight to moderate congestion of capillaries and larger vessels was ob-
served. The same lesions were located in the cranial and slightly in the
caudal lobes. An increased quantity of the mucus and a slight oedema
in the mucosa or submucosa were seen in the trachea.In the brain, only slight hyperaemia and perivascular or pericellular
oedema and slight vacuolization or colliquative (lytic) changes in the
cortex of the brain as well as lytic changes in some of the neurons and
glia cells were seen. A slight focal proliferation of the glia cells was
also observed. Slight hyperaemia and oedema were seen in the brain
envelopes and/or ventricles (Fig. 5).
In the cerebellum, there were only slight edema and degenerative
changes (mainly lysis) in the region of the Purkinje's cells as well as
slight lytic or colliquative changes in the corpus medullare or laminae
medullares of white matter. A slight hyperaemia of some vessels was
also seen.
In the kidneys, themost commonpathomorphological changeswere
the slight or moderate vacuolar/granular or hyaline degeneration in the
epithelium of proximal tubules, the hyperaemia of vessels and/or
peritubular capillaries, the slight activation of capillary endothelium,
the perivascular or pericapillary edema and the slight enlargement of
lymphatic spaces. Hyaline casts were seen in some tubules. Slight
oedematous changes were seen around the ureters of some pigs.
Fig. 5. Slight hyperaemia and oedema in the brain envelopes. Brain of pig given FB1 and
infected with Pasteurella multocida. X/E. ×200.
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degeneration, in some hepatocytes and/or irregular staining (eosino-
philia or cloudy swelling). A slight hyperaemia of vessels and slight ac-
tivation of capillary endothelium were also observed.
In the spleen, there was only a slight hyperaemia and a slight en-
largement or oedema in the trabeculae. A slight predomination of im-
mature lymphocytes in the lymph follicles and rareﬁed white pulp
were observed. A slight predomination of the red pulp over the white
pulp in some of the pigs was also seen.
In the mesenterial lymph nodes enlargement and hyperplasia of
lymph follicles and lymphoid tissuewere rarely seen in someof the pigs.
In the small- and large intestines, slight degenerative changes in su-
perﬁcial epithelium or slight increasing of the glandular secretion such
as increasing of the quantity of Goblet cells and a local histiocyte/lym-
phocyte proliferation in mucosal propria, were rarely seen (Fig. 6).
In the myocardium, there was only irregular staining or slight lytic
changes in some myoﬁbrils.4. Discussion
FB1 was found to have a suppressing effect on phagocytic activity of
pulmonary macrophages and to prevent the removal of particulateFig. 6. Degenerative changes in superﬁcial epithelium and increased quantity of Goblet
cells. Jejunum of pig given FB1 and infected with Pasteurella multocida. X/E. ×200.matter and bacteria from the circulation (Smith et al., 1996). This cir-
cumstance is considered to be a possible reason for the increased sus-
ceptibility to P. multocida infection in swine (Halloy et al., 2005) as
seen in the present study. It was also supposed, that the increased sus-
ceptibility of porcine pulmonary capillary endothelium to FB1
(Gumprecht et al., 2001) may also contribute to the increased suscepti-
bility to infectious and/or inﬂammatory diseases (Halloy et al., 2005),
which was supported in the present study. Some other studies have
also conﬁrmed the pro-inﬂammatory effects of FB1 and contributed sig-
niﬁcantly to the explanation of these effects via some investigations on
the cytokine proﬁle of FB1 exposed pigs (Taranu et al., 2005).
The FB1-induced increase in the permeability of vessels could also con-
tribute to the dissemination of various infections in the lung of pigs,
resulting in further distribution and aggravation of pneumonic damages
out of its typical localisation as was seen in this study. This process
could be facilitated by the immunosuppressive effect of FB1 on humoral
immune response in pigs (Stoev et al., 2012). In this regard, a study of
Ramos et al. (2010) demonstrated that lung damages are much compli-
cated in swine inoculated with PRRS virus, when the same are exposed
additionally to FB1 in the feed diet. The authors explained this deteriora-
tion of the disease by immunosuppressive effect of FB1, supposed to be
due to the accumulation of free sphingoid bases and a subsequent inhibi-
tion of lymphocytes proliferation (Taranu et al., 2005).
In the literature, there are some controversial evidences about the
adverse effect of FB1 on pigs. Some authors report that even high feed
levels of FB1 such as 40 ppm don't affect feed intake and body weight
gain. Pigs exposed to suchhigh contamination levels of FB1 develop usu-
ally a strong pulmonary oedema which, however, is not always accom-
panied with visible clinical signs (Tóth et al., 2000). Such clinical signs
can develop only after exposure to very high doses of FB1 such as
100–300 ppm (Harrison et al., 1990; Haschek et al., 1992). However,
other studies revealed that dietary exposure of pigs to signiﬁcantly
lower feed levels of FB1 such as 1–10 ppm, can provoke a partial de-
crease in bodyweight gain in the ﬁrst 4weeks of life, which can be com-
pensated in a later stage (Rotter et al., 1996). In this regard, our studies
support the observations of the authors who observed no visible clinical
signs and signiﬁcant differences in the body weight of the pigs exposed
to high levels FB1, but it should be taken into account that our levels of
FB1 were signiﬁcantly lower than the levels used by these authors.
Some previous studies of Zomborszky-Kovács et al. (2002) revealed
that the pulmonary oedema usually appears in the early stage of
fumonisin exposure, whereas in the later stages (N6–8 weeks of expo-
sure to low doses 1–10 ppm of FB1) a pulmonary ﬁbrosis is observed,
often without any clinical signs (Zomborszky-Kovács et al., 2002). The
clinical manifestation may only appear after much higher doses of FB1
(100–300 ppm or above 15 mg/kg b.w.) as reported by Harrison et al.
(1990) and Haschek et al. (1992) and this ﬁnding was conﬁrmed in
the present study, where no clinical signs were observed in FB1 treated
pigs.
The slight enlargement of mesenterial lymph nodes and the slight
hyperaemia in mesenterial vessels observed in some of the control pigs
can be attributed to some individual features and/or to the small foci of
local peritonitis seen in most of the pigs (experimental and control),
due to intraperitoneal injections with ovalbumin.
Themost obvious changes in FB1 exposed pigs can be considered as a
result of the increased permeability of vessels, which is responsible for
perivascular and especially pericapillary oedema in the lung, brain, cer-
ebellum and partially in kidneys seen in the present study. However,
these oedematous changes were much stronger in the lung than in
the other organs. It is also reported that FB1 can decrease myocardial
contractility in pigs. Such decrease could be due to sphingosine
inhibiting the L-type calcium channels in the myocardium (Haschek et
al., 2009). This heart damage could additionally contribute to the
oedematous changes in the lung. The lung oedema of pigs exposed to
FB1 is similar to that described in our previous studies
(Zomborszky-Kovács et al., 2000; Pósa et al., 2011, 2013; Stoev et al.,
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non-inﬂammatory origin found in the peribronchial, peribronchiolar
and perivascular areas of the lungs (Fazekas et al., 1998; Haschek et
al., 1992).
FB1 has been reported to be a nephrotoxic for kidney (Bucci et al.,
1998; Voss et al., 2001; Howard et al., 2001) and to provoke in vitro
and in vivo degenerative and/or apoptotic damages in tubular epitheli-
um of kidneys in rats or pigs (Dragan et al., 2001, Stoev et al., 2012),
which was conﬁrmed by the present study. FB1 is also reported to im-
pair protein synthesis in cells, which could lead to further degenerative
changes in kidneys or liver, the target organs responsible for elimination
or detoxiﬁcation of mycotoxins (Abado-Becognee et al., 1998).
The lung is also the target organ of the P.multocida-induced damage,
but the pathomorphological changes corresponded to the morphologic
pattern of a broncho-interstitial pneumonia, with development of
prominent interalveolar, peribronchiolar, peribronchial and
perivascular mononuclear inﬁltration. These changes were quite differ-
ent as compared to the lung changes provoked by FB1.
Histopathological damages in P.multocida infected pigswere similar,
but less expressed than those described by Halloy et al. (2005), who ob-
served inﬂammatory mononuclear proliferation in the interstitium of
lung. Mononuclear and neutrophils inﬁltration in the interstitium and
alveolar or bronchial lumina in the present experimentweremainly ob-
served in infected animals compromised by FB1, which is in agreement
with pathomorphological ﬁndings reported by Halloy et al. (2005).
A complicated course of P.multocida serotype A infection is also ob-
served when the same pathogen is interactedwith other respiratory in-
fectious agents (Amass et al., 1994; Ciprian et al., 1988; Pósa et al., 2011)
instead FB1.
It can be concluded, that pathomorphological changes in various in-
ternal organs in the pigs of the group infected with P. multocida and
treated simultaneouslywith FB1 should be considered not only as a sim-
ple combination of the pathomorphological changes characteristic for
both: P. multocida infection and FB1 intoxication, but also as a complica-
tion and deterioration of the same changes. One of the target changes in
the pigs of this group is due to the increased permeability of vessels
leading to a strong perivascular and especially pericapillary oedema in
the lung and subsequently in decreasing order in the brain, cerebellum
and kidneys, which can be considered as a consequence of FB1 action.
The other target damage was seen also in the lung, where a focal bron-
cho-interstitial pneumonia, with peribronchial, peribronchiolar and
perivascular inﬂammatory cell inﬁltration and/or intra-alveolar/intra-
bronchiolar leucocyte inﬁltration were also seen, which was mainly
due to the complicated P. multocida infection.
We can conclude that FB1 exposure of pigs may complicate or exac-
erbate the course of P. multocida serotype A infection as was demon-
strated in the present study. Some additional experiments would be
necessary in order to clarify more precisely the target mechanism and/
or the extent of this exacerbation.
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